Mark Davies

Prediction of Thorough QT study results using action potential simulations based on ion channel screens

Gary R. Mirams, Mark Davies, Stephen Brough et al. · Journal of Pharmacological and Toxicological Methods · 2014 · 96 citations · Full text

Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone

Y. Lee, Edward M. Schwarz, Mark Davies et al. · Journal of Orthopaedic Research® · 2002 · 93 citations · Full text

Sclerostin, Pathology, Prostate Adenocarcinoma +18

Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment

Ryan C. Elkins, Mark Davies, Stephen Brough et al. · Journal of Pharmacological and Toxicological Methods · 2013 · 91 citations · Full text

Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.

Yu-Po Lee, Edward M. Schwarz, Mark Davies et al. · PubMed · 2002 · 90 citations

Tissue Engineering, Bone Repair, Prostate Adenocarcinoma +17

An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessment

Mark Davies, Hitesh Mistry, Leyla Hussein et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2011 · 85 citations

Cardiac Muscle, Heart Failure, Cardiac Anaesthesia +21